ATH 0.00% 0.5¢ alterity therapeutics limited

Ann: First Patient dosed in ATH434 Phase 2 Clinical Trial, page-9

  1. 405 Posts.
    lightbulb Created with Sketch. 38
    I was expecting at least end of Q3
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.